• Home
  • |
  • Organization
  • |
  • Contacts
  • |
  • Pharmacovigilance
  • |
  • Chiesi Group world.png
  • SE
  • EN
Welcome to Chiesi
SVERIGE
Enter at least 3 characters
MENU
  • About us
    • Our company
    • Organization
    • Our history
    • Chiesi globally
    • Mission And Values
    • Our partnerships
    • Compliance
    • Annual & sustainability report
  • Therapeutic areas
    • General
    • Respiratory
    • Neonatology
    • Rare diseases
    • Special care
  • Working at Chiesi
    • Our Commitment
    • Develop at Chiesi
    • Join our team
    • Meet Our People
  • Research and development
    • Sponsored academic collaborations
    • Pipeline
    • Production plants
  • Media
    • News and press release
  • Sustainability
    • Sustainability at Chiesi
    • How Chiesi work with sustainability
    • Shared value
    • Chiesi Pharma's sustainability goals
    • Our B Corp certification
    • Sustainability reports
    • Summary of Nordic Sustainability actions 2020
    • SpeakUp&BeHeard
  • Sustainability in Chiesi
  • HOW CHIESI WORK WITH SUSTAINABILITY
  • NEONATOLOGY
  • RARE DISEASES
  • RESPIRATORY DISEASES
  • SPECIAL CARE
  • icon_polmoini_B.png
    Respiratory
     
    btnaree.png
    icon_polmoini_B.png
    Respiratory
     
    btnaree.png
  • icon_neonato_B.png
    Neonatology
    CHIESI – A RESULT OF SUCCESSFUL...
    btnaree.png
    icon_neonato_B.png
    Neonatology
    CHIESI – A RESULT OF SUCCESSFUL...
    btnaree.png
  • icon_malattierare_B.png
    Rare diseases
    RARE DISEASES Rare diseases, or uncommon...
    btnaree.png
    icon_malattierare_B.png
    Rare diseases
    RARE DISEASES Rare diseases, or uncommon...
    btnaree.png
  • ic_sp_ca_off.png
    Special care
    Kidney and liver failure – organ...
    btnaree.png
    ic_sp_ca_off.png
    Special care
    Kidney and liver failure – organ...
    btnaree.png
Chiesi fortsätter att vara en av Sveriges bästa... btnricerca.png
Chiesi outlines €350 million investment and... btnricerca.png
PUBLICATIONS
84_sustainability-report-2024--281-29.jpg
2025
Sustainability report 2024
download.png Download PDF
version
Other publications plus.png

Chiesi Group announces the passing of Honorary President Dr. Paolo Chiesi ...

© 2025 Chiesi Pharma AB
Klara Norra kyrkogata 34, 111 22 Stockholm
Telefon +46 8 753 35 20
E-post infonordic@chiesi.com

R&D, Global Rare Diseases
Chiesi Pharma AB, Scheeles väg 2, 171 65 Solna
Telefon + 46 8 753 35 20

Updated at 17/10/2023
  • Sitemap
  • Cookies
  • Credits
  • Credits
  • Privacy policy
  • SpeakUp&BeHeard
CHIESI ON THE WEB
mappa.png
CHIESI ON THE WEB
Austria
Chiesi Pharmaceuticals GmbH
Belgium
Chiesi sa
Brazil
Chiesi Farmacêutica Ltda
Bulgaria
Chiesi Bulgaria Ltd.
China
Chiesi Pharmaceutical (Shanghai) Co., Ltd
Czech Republic
Chiesi CZ s.r.o.
Germany
Chiesi GmbH
Greece
Chiesi Hellas Pharmaceuticals S.A.
Hungary
Chiesi Hungary Kft.
Italy
-
Mexico
Chiesi Mexico S.A. de C.V.
Pakistan
Chiesi Pharmaceuticals (Pvt) Limited
Poland
Chiesi Polonia
Romania
Chiesi România S.r.l.
Russian Federation
Chiesi Pharmaceuticals LLC
Scandinavia
Chiesi Pharma AB
Slovak Republic
Chiesi Slovakia s.r.o
Slovenia
Chiesi Slovenija, d.o.o
Spain
Chiesi España S.A.
The Netherlands
Chiesi Pharmaceuticals B.V.
Turkey
Chiesi İlaçTicaret Limited Sirketi  A.Ş.
United Kingdom
Chiesi Ltd
United States
Chiesi Usa Inc.